SecBot SecBot
424B5 ·Filed Nov 20, 2026

NIVF

NewGenIvf Group Ltd
BEARISH
Impact 7/10
Horizonimmediate Processed1d 22h ago SEC0001213900-26-122441
Notable filing: 424B5
Actionable Insight ▼ Bearish

Monitor the stock price for further decline given the massive dilution and the 79.4% discount. The company's ability to maintain its Nasdaq listing is in serious doubt after ten reverse splits and a cumulative ratio far exceeding the 250-to-1 threshold that eliminates the standard bid-price compliance period. Watch for the planned 1-for-100 reverse split on December 1, 2026 and any Nasdaq delisting notice.

DirectionBearish
Confidencehigh
Horizonimmediate
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

NewGenIvf Group Limited is conducting a deeply discounted firm-commitment underwritten offering of 1,150,570 Class A ordinary shares at $0.035 per share (a 79.4% discount to the $0.17 last reported sale price on November 18, 2026) and 70,278,000 pre-funded warrants at $0.03499 each. The offering raises approximately $2.5 million in gross proceeds ($2.095 million net), with $625,000 used to repurchase a portion of an outstanding convertible note. The offering is massively dilutive: the pre-funded warrants alone represent over 21x the current Class A shares outstanding, and the company faces imminent Nasdaq delisting risk after ten reverse stock splits with a cumulative ratio of ~17,280,000-to-1.

Key Financial Metrics

Offering Size
$2.5M
Dilution
2138%
Lock-up
60 days
Underwriters
Aegis Capital Corp.

Key Facts

  • Offering of 1,150,570 Class A shares at $0.035/share, a 79.4% discount to the $0.17 last reported sale price on November 18, 2026
  • 70,278,000 pre-funded warrants offered at $0.03499 each, exercisable at $0.00001 per share, immediately exercisable with a 4.99% beneficial ownership limitation
  • Total gross proceeds of $2,499,297; net proceeds estimated at $2.095 million after underwriting discounts ($225,000) and estimated expenses ($180,000)
  • $625,000 of gross proceeds used to repurchase $584,112 principal amount of an outstanding senior convertible note
  • Current shares outstanding: 3,286,775 Class A and 9,136 Class B; after full exercise of pre-funded warrants, Class A shares would rise to 74,715,345 (over 22x current)
  • Company has effected ten reverse stock splits since February 2025 with a cumulative ratio of approximately 17,280,000-to-1; another 1-for-100 reverse split is tentatively scheduled for December 1, 2026
  • Under Nasdaq Rule 5810(c)(3)(A)(iv), the company could face delisting without the ordinary 180-day compliance period due to the cumulative reverse split ratio exceeding 250-to-1 within two years
  • Revenue declined from $2,019,628 (H1 2025) to $1,924,881 (H1 2026); net income swung from $698,032 to a loss of $(8,079,392)
  • Market cap is $2M; the offering size ($2.5M gross) exceeds the entire market cap
  • Aegis Capital Corp. is sole book-running manager on a firm commitment basis; 60-day lock-up for officers, directors, and 5%+ shareholders; 60-day company standstill

Financial Impact

Gross proceeds of $2,499,297; net proceeds of $2,095,000 after $225,000 underwriting discount and ~$180,000 expenses. The offering is massively dilutive: the pre-funded warrants alone represent 70,278,000 shares, or approximately 2,138% of the current 3,286,775 Class A shares outstanding. Pro forma net tangible book value per share drops from $119.311 to $0.089.

dilutionshare countcashdebt reduction

Risk Factors

  • Imminent Nasdaq delisting risk: cumulative reverse split ratio of ~17,280,000-to-1 exceeds the 250-to-1 threshold under Rule 5810(c)(3)(A)(iv), eliminating the ordinary 180-day compliance period for bid price deficiencies
  • Massive dilution: pre-funded warrants represent over 21x the current Class A shares outstanding; full exercise would increase Class A shares from 3.3M to 74.7M
  • Deeply discounted offering price ($0.035) is well below Nasdaq's $1.00 minimum bid price, increasing delisting risk
  • Revenue declining and net loss widening: revenue fell 4.7% YoY and net income swung from +$698K to -$8.1M in H1 2026
  • Company has a history of repeated reverse stock splits (10 in ~21 months) and has an additional 1-for-100 split planned
  • Use of proceeds includes speculative investments in prediction-market and digital-asset/AI initiatives, real estate in UAE, and general corporate purposes with broad management discretion
  • Outstanding convertible notes of $5.8M (after partial repurchase) and other debt financing arrangements create additional dilution and financial strain
  • document contains text addressed to automated readers

Market Snapshot

Exchange
Nasdaq
Sector
Services-Misc Health & Allied Services, NEC

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
424B5 Filing (Primary)0001213900-26-122441
Document: 0001213900-26-122441-index-headers.html0001213900-26-122441
Document: 0001213900-26-122441-index.html0001213900-26-122441
Document: 0001213900-26-122441.txt0001213900-26-122441

Track record

27 reports on NIVF

Performance horizon

10 of 12 bullish or bearish reports moved the stock their way by T+20. Best: +99.57% at T+60 after the Aug 20, 2026 report. 14 of 14 went positive at some point.

Filters
  1. Nov 20, 20261d ago 424B5 Bearish 7/10 Viewing Entry $0.0318 Now $0.0270 +15.09% settles Dec 21
  2. Nov 19, 20262d ago 424B5 Bearish 6/10 Entry $0.0350 Now $0.0270 +22.86% settles Dec 18
  3. Nov 17, 20264d ago 6-K Neutral 2/10 Entry $0.1728 Now $0.0270 −84.37% settles Dec 16
  4. Nov 16, 20265d ago 6-K Neutral 3/10 Entry $0.2050 Now $0.0270 −86.83% settles Dec 15
  5. Nov 13, 20269d ago EFFECT Bearish 5/10 Entry $0.2312 Now $0.0270 +88.32% settles Dec 14
  6. Oct 21, 20264w ago 6-K Neutral 4/10 Entry $0.1884 Now $0.0270 −85.67% due Nov 18
  7. Oct 7, 20266w ago 6-K Bearish 7/10 Entry $0.0811 to $0.0152 Now $0.0270 +66.71% ▲ +81.23% +75.94% vs SPY
  8. Oct 7, 20266w ago 6-K Neutral 3/10 Entry $0.1060 to $0.0216 Now $0.0270 −74.53% ▼ −79.58% −78.24% vs SPY
  9. Oct 6, 20266w ago SC 13D/A Neutral 3/10 Entry $0.0987 to $0.0266 Now $0.0270 −72.64% ▼ −73.09% −69.91% vs SPY
  10. Oct 5, 20266w ago 6-K Bearish 6/10 Entry $0.1100 to $0.0306 Now $0.0270 +75.45% ▲ +72.16% +69.70% vs SPY
Showing 10 of 27

US Market Status

Market Closed · Opens Mon (26h 28m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 20, 2026